857680-70-7Relevant academic research and scientific papers
4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters
Alberati, Daniela,Hainzl, Dominik,Jolidon, Synese,Kurt, Anke,Pinard, Emmanuel,Thomas, Andrew W.,Zimmerli, Daniel
, p. 4321 - 4325 (2007/10/03)
A novel class of 4-substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-ones have been discovered and developed as potent and selective GlyT1 inhibitors. The molecules are devoid of activity at the GlyT2 isoform and display excellent selectivities against the μ opioid receptor as well as the nociceptin/orphanin FQ peptide (NOP) receptor. These molecules also exhibit superior pharmacological and pharmacokinetic parameters, relative to all GlyT1 inhibitors of the spiropiperidine family, culminating in the identification of 16b with an oral bioavailability of ～60%. In addition, a straightforward two-step procedure for the assembly of the target molecules is also presented.
Diaza-spiropiperidine derivatives
-
Page/Page column 9, (2010/02/12)
The present invention relates to compounds of formula wherein A—B, R1, R2, R3, R4, and n are as defined herein; and to pharmaceutically acceptable salts thereof. The compounds of formula I may be used in the tre
